Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,166.8
-16.2 (-0.51%)

 

  • STI Straits Times Index
    3,166.8
    -16.2 (-0.51%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.5
    -4.8 (-0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,754.1
    -36.1 (-0.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,985.7
    7.5 (0.25%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,960.7
    -40.6 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,276.6
    39.9 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,070.7
    8.4 (0.41%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.2
    -10.5 (-0.15%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 726.6M
  • Value: 896.1M
  • Rise: 134
  • Fall: 155
  • Unch: 544

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.088-0.005
TEE Intl0.046+0.004
YZJ Shipbldg SGD1.050-0.030
Spackman0.013+0.001
Mapletree Ind Tr2.400+0.070
Keppel DC Reit1.970+0.040
Kep Infra Tr0.525+0.005
LionGold0.001-
Medtecs Intl0.039+0.007
Mapletree Com Tr2.220+0.060

World Indices

World Indices
Name Last Change
Nasdaq 8,186.0 +32.5
HSI 26,754.1 -36.1
HSCEI 10,478.5 -23.9
Jakarta 6,276.6 +39.9
Nikkei 225 21,960.7 -40.6
SSE Comp 2,985.7 +7.5
Shanghai A 3,127.8 +7.9
Shanghai B 271.6 +0.9
PSE Comp 0.0
KOSPI 2,070.7 +8.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PUMA BIOTECHNOLOGY INC PUMA BIOTECHNOLOGY
Updated on 17 Sep 2019 (End of trading day)
Last (USD): 11.660 Change: -0.110 High: 11.827 Remarks: -
Change (%): -0.93 Low: 10.950
Open 11.760 Yesterday's Close 11.77
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 975,378 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.91989 Trailing EPS (USD) e -2.37581 NAV (USD) b 0.5597
PE a - Trailing PE f - Price / NAV b 20.8326
Dividend (USD) d - Cash In Hand (USD) g 0.6984 Issued & Paid-up Shares c 38,897,000
Dividend Yield (%) d - Price / Cash In Hand g 16.695 Treasury Shares h -
Beta - 75 Daysi 0.281 R-Squared - 75 Days(%)i 0.37 Market Cap (M) 453.539
Beta - 500 Daysi -0.081 R-Squared - 500 Days (%)i 0.05 Enterprise Value (M) 455.639
Piotroski F Score 3 Exchange Code PBYI Par Value ( $ ) n.a.
52 Weeks Volatility (%) 109.33 Free Float (%) 86.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Jan 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PUMA BIOTECHNOLOGY INC NASDAQ 453.539 - - 20.8326 -
Industry Biotechnology NASDAQ 2,230.736 126.999 97.907 5.1636 0.799
Local Peer AMGEN INC NASDAQ 117,973.181 14.054 14.824 10.9295 2.818
Local Peer GILEAD SCIENCES INC NASDAQ 83,800.996 15.362 14.072 3.7054 3.488
Local Peer CELGENE CORP NASDAQ 69,881.863 17.272 13.258 6.9527 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 45,238.160 21.579 20.424 8.9228 -
Local Peer ILLUMINA INC NASDAQ 43,845.690 53.082 46.744 10.1213 -
Local Peer BIOGEN INC NASDAQ 44,027.499 9.937 8.316 3.3990 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 31,662.760 12.953 15.302 3.2455 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,178.397 311.575 18.130 2.3789 -
Local Peer INCYTE CORPORATION NASDAQ 17,011.800 155.369 55.618 7.5702 -
Local Peer EXACT SCIENCES CORP NASDAQ 13,838.062 - - 18.0765 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,459.725 - - 4.5457 -
Local Peer SEATTLE GENETICS INC NASDAQ 12,149.693 - - 9.5530 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GENOMIC HEALTH INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), OMEROS CORP (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DERMIRA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MERUS B V (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARDELYX INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), KAMADA (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CHIMERIX INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TREVENA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ORGENESIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EQUILLIUM INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ARAVIVE INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), HISTOGENICS CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TROVAGENE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ADVAXIS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 106,410.911 39.662 39.662 14.2200 1.132
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,643.355 74.821 22.055 4.9807 0.802
Global Peer SINO BIOPHARM HKEx 135,076.224 12.606 13.010 3.9683 0.681
Global Peer WUXI BIO HKEx 97,099.387 130.002 101.632 9.9953 -
Global Peer BEIGENE HKEx 62,029.143 - - 5.1096 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 31,734.100 20.978 25.533 3.1278 -
Global Peer GENSCRIPT BIO HKEx 31,656.040 190.370 - 8.9272 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,751.312 43.880 - 2.7822 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), MESOBLAST LTD (ASX), AVITA MEDICAL LTD (ASX), ASCLETIS-B (HKEx), MYOVANT SCIENCES LTD (NYSE), CKLIFE SCIENCES (HKEx), ARCUS BIOSCIENCES INC (NYSE), NEXT SCIENCE LTD (ASX), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), LEE'S PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), DPHARMA (Bursa), ENZO BIOCHEM INC (NYSE), PALATIN TECHNOLOGIES INC (NYSE American), UNI-BIO GROUP (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), BBI LIFE SCI (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), RESAPP HEALTH LIMITED (ASX), CEL-SCI CORP (NYSE American), PHYLOGICA LIMITED (ASX), PORT (SET), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IMUGENE LIMITED (ASX), IBIO INC (NYSE American), IMMUTEP LTD (ASX), CT ENTERPRISE (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), ORTHOCELL LIMITED (ASX), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), ISORAY INC (NYSE American), PATRYS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOVIRICIDES INC (NYSE American), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HAO WEN HLDGS (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), AVECHO BIOTECHNOLOGY LTD (ASX), MEGASUN (Bursa), ACTINOGEN MEDICAL LTD (ASX), QT Vascular (SGX), NOVITA HEALTHCARE LTD (ASX), AIM IMMUNOTECH INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.220
-1.85 %
10 Days -+1.230
+11.79 %
20 Days -+0.700
+6.39 %
Medium Term Return 3 Months --2.390
-17.01 %
6 Months --27.830
-70.47 %
1 Year --36.140
-75.61 %
Long Term Return 2 Years --95.140
-89.08 %
Annualised Return Annualised --
-66.96 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.450 - 49.200 Change From 1 Year Low +3.210 % Change From 1 Year Low (%) +37.99
Change From 1 Year High -37.540 % Change From 1 Year High (%) -76.30
2 Years Range 8.450 - 136.900 Change From 2 Years Low +3.210 % Change From 2 Years Low (%) +37.99
Change From 2 Years High -125.240 % Change From 2 Years High (%) -91.48
5 Years Range 8.450 - 136.900 Change From 5 Years Low +3.210 % Change From 5 Years Low (%) +37.99
Change From 5 Years High -125.240 % Change From 5 Years High (%) -91.48
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2019 11.760 11.827 10.950 11.660 975,378 -
16 Sep 2019 11.230 11.810 11.020 11.770 1,437,030 -
13 Sep 2019 11.590 11.820 10.940 11.300 1,224,339 -
12 Sep 2019 11.840 11.880 11.300 11.590 1,363,762 -
11 Sep 2019 12.800 12.990 11.655 11.880 1,864,366 -
10 Sep 2019 10.800 12.510 10.640 12.490 2,621,483 -
09 Sep 2019 10.810 10.920 10.340 10.840 1,015,311 -
06 Sep 2019 10.940 11.180 10.630 10.760 1,026,894 -
05 Sep 2019 10.520 11.010 10.370 10.970 1,091,215 -
04 Sep 2019 11.280 11.290 10.041 10.430 1,805,932 -
03 Sep 2019 10.640 10.750 9.601 10.430 1,517,717 -
30 Aug 2019 10.900 11.080 10.650 10.750 1,030,929 -
29 Aug 2019 11.020 11.160 10.560 10.830 708,411 -
28 Aug 2019 10.530 11.140 10.420 10.930 797,971 -
27 Aug 2019 11.100 11.300 10.520 10.540 860,358 -
26 Aug 2019 11.150 11.350 10.800 10.960 941,492 -
23 Aug 2019 11.130 11.430 10.930 10.990 1,048,157 -
22 Aug 2019 11.000 11.335 10.880 11.190 1,174,364 -
21 Aug 2019 10.780 10.980 10.519 10.960 757,993 -
20 Aug 2019 10.180 10.845 10.070 10.780 1,282,270 -
19 Aug 2019 9.530 10.280 9.500 10.200 1,291,674 -
16 Aug 2019 9.550 9.785 9.290 9.380 1,604,514 -
Summary
Current 2 Weeks
(04 Sep 2019 to 17 Sep 2019)
11.280 12.990 10.042 11.660 14,425,710 -
Previous 2 Weeks
(20 Aug 2019 to 03 Sep 2019)
10.180 12.990 10.042 10.430 10,119,662 -
4 Weeks from
(23 Jul 2019 to 19 Aug 2019)
10.050 12.990 9.630 10.200 34,975,645 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.